Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants

Authors:
Open Access
Publisher website
Google Scholar
Abstract
In light of multiple variants of SARS-CoV-2 that have been documented globally during the COVID-19 pandemic, it remains important to continually assess the ability of currently available vaccines to confer protection against newly emerging variants. Data presented herein indicate that immunization with the mRNA-1273 COVID-19 vaccine produces neutralizing antibodies against key emerging variants tested, including variants of concern and variants of interest.
All Related Versions
Funding Information
  • Moderna, Inc.

This publication has 11 references indexed in Scilit: